NewLink Genetics Corporation (NASDAQ: NLNK) today announced the company initiated a project to develop new treatment options for the Zika ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE